ALYN BENEZETTE: Open Payments
NPI 1508863572 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 105 payments from 19 companies in 2025. Trend: 2023 $2,475 · 2024 $2,104 · 2025 $2,312
Food & beverage: $2,312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $617 |
| PFIZER INC. | 21 | $389 |
| PROTEGA PHARMACEUTIALS INC | 4 | $267 |
| Eisai Inc. | 8 | $201 |
| Novartis Pharmaceuticals Corporation | 8 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $153 |
| UCB, Inc. | 4 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| ARGENX US, INC. | 2 | $67 |
| EMD Serono, Inc. | 2 | $47 |
Products named: ROXYBOND, QULIPTA, Leqembi, UBRELVY, ZAVZPRET, KESIMPTA, NURTEC ODT, RELISTOR.
Industry payments across FL — which companies pay providers there.
